secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001437749-26-008951
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech posts investor presentation; no material new information
--------------------------------------------------------------------------

- Presentation furnished under Item 7.01 on March 19, 2026.
- No financial results, operational updates, or guidance provided in the filing.
- Presentation is not incorporated by reference into SEC filings.
- Exhibit 99.1 is an image exhibit with no extractable text or data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926008951/0001437749-26-008951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926008951/mbrx20260318_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-008951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer